Comments

Sarepta Therapeutics Stock Guidance

SRPTNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$71.48
-0.33-0.46%
Pre-Market: 5:37 PM EDT
Sarepta Therapeutics (SRPT) ForecastNewsEarningsSarepta Therapeutics (SRPT) Options

Guidance

DividendsAnalyst RatingsInsider TradesGovernment TradesShort Interest

Sarepta Therapeutics Stock Guidance | NASDAQ:SRPT | Benzinga

Sarepta Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
08/02/2022SRPT
Sarepta Therapeutics
FY2022———$905.00M$920.00M$899.91MGet Alert
03/01/2022SRPT
Sarepta Therapeutics
FY2022———$880.00M—$908.46MGet Alert
01/10/2022SRPT
Sarepta Therapeutics
Q42021———$178.70M$178.70M$197.25MGet Alert

FAQ

Q

What is the most recent guidance for Sarepta Therapeutics (SRPT)?

A

There have been no specific sales or earnings guidance reported for Sarepta Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved